Direktif untuk semua produk yang mengandungi filgrastim, pegfilgrastim dan lenograstim: Pengemaskinian sisip bungkusan dengan maklumat keselamatan berkaitan aortitis.
- Posted By Jauze
- Jumlah paparan: 9682
Kadar pengguna: 1 / 5
 |
 |
 |
 |
National Pharmaceutical Regulatory Agency (NPRA)
Lot 36, Jalan Universiti (Jalan Prof Diraja Ungku Aziz), 46200 Petaling Jaya, Selangor, Malaysia.
- Phone: +603-7883 5400
More Links
More Links
DISCLAIMER
The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.
Site Last Modified
- Last Modified: Jumaat 20 Disember 2024, 19:30:56.